Loading chat...

CT HB05962

Bill

Official Source

Status

Introduced

1/19/2017

Primary Sponsor

Insurance and Real Estate Committee

Click for details

Origin

House of Representatives

2017 General Assembly

AI Summary

  • Prohibits insurance companies and health care entities from requiring step therapy for prescription drugs longer than 60 days for any condition.

  • Exempts all cancer treatment drugs prescribed to insureds diagnosed with stage IV metastatic cancer from step therapy requirements.

  • Allows a treating health care provider to deem a step therapy regimen clinically ineffective after the time period expires, requiring insurers to authorize and cover the prescribed drug.

  • Applies to both individual health insurance policies (section 38a-510) and group health insurance policies (section 38a-544).

  • Effective January 1, 2018.

Legislative Description

An Act Prohibiting Insurers From Using Step Therapy For Prescription Drugs Prescribed To Treat Stage Iv Metastatic Cancer.

Last Action

Favorable Change of Reference, Senate to Committee on Appropriations

3/17/2017

Committee Referrals

Appropriations3/9/2017
Insurance and Real Estate1/19/2017

Full Bill Text

No bill text available